PT-141 (Bremelanotide) is an innovative peptide therapy clinically shown to enhance sexual desire and treat sexual dysfunction in both men and women. As a melanocortin receptor agonist, PT-141 works by stimulating specific pathways in the brain, helping address low libido and sexual arousal disorders. Initially FDA-approved for premenopausal women with hypoactive sexual desire disorder (HSDD), it is also used off-label for men facing erectile dysfunction (ED) or low sexual desire. PT-141 offers new hope where traditional hormone or blood flow-based therapies may not be effective.
Unlike traditional sexual health therapies that focus on hormone levels or blood circulation, PT-141 acts directly on the central nervous system. By activating melanocortin receptors in the brain, it increases sexual desire and arousal, supporting both male and female patients. PT-141’s unique mechanism may provide quicker, natural-feeling results without relying solely on testosterone levels or vascular function. This makes it an excellent alternative for individuals who have not responded well to oral medications like Viagra or Cialis.
PT-141 therapy begins with a comprehensive medical evaluation to confirm clinical appropriateness and rule out contraindications. It may not be suitable for individuals with certain cardiovascular conditions or uncontrolled hypertension.
Our medical team conducts thorough screening to assess candidacy and address any health considerations before therapy begins.
At Premier Hormone Health & Wellness, your journey starts with a personalized telehealth consultation. Our licensed providers assess your health history, symptoms, and goals to craft a treatment plan tailored to you. Through secure virtual visits, you have ongoing access to expert care—no matter where you are in the United States. Your PT-141 prescription is filled by certified compounding pharmacies and shipped to your home, always in discreet packaging to protect your privacy.
PT-141 is typically administered as a subcutaneous injection, taken shortly before anticipated sexual activity. Dosing is individualized, but many adults start with 1.75 mg injected into the abdomen or thigh, about 45 minutes to one hour before intimacy. Frequency of use is generally limited to a few times per week, as directed by your provider.
Our clinical team provides detailed guidance and instruction to help you administer each dose correctly and with confidence from home.
Most patients tolerate PT-141 well, though mild side effects may occur. Common symptoms include:
Rare but serious effects (e.g., increased blood pressure, allergic reaction) are discussed thoroughly during your consult, and our providers monitor your progress closely. If you experience any side effects, our care team is available for immediate support and adjustment of your treatment if needed.
Provider-supervised care tailored to your bloodwork and goals. Free consultation included.


